[go: up one dir, main page]

AUPP076797A0 - Phospholipase inhibitor - Google Patents

Phospholipase inhibitor

Info

Publication number
AUPP076797A0
AUPP076797A0 AUPP0767A AUPP076797A AUPP076797A0 AU PP076797 A0 AUPP076797 A0 AU PP076797A0 AU PP0767 A AUPP0767 A AU PP0767A AU PP076797 A AUPP076797 A AU PP076797A AU PP076797 A0 AUPP076797 A0 AU PP076797A0
Authority
AU
Australia
Prior art keywords
phospholipase inhibitor
phospholipase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP0767A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACTIVE (PLA) R&D Pty Ltd
APELDA (PLA) R&D Pty Ltd
EDZELL (PLA) R&D Pty Ltd
FLAIR (PLA) R&D Pty Ltd
HERACLES (PLA) R&D Pty Ltd
HSC (PLA) Pty Ltd
NORTHMOOR (PLA) R&D Pty Ltd
Original Assignee
Active Pla R & D Pty Ltd
Apelda Pla R & D Pty Ltd
Edzell Pla R & D Pty Ltd
Flair Pla R & D Pty Ltd
Heracles Pla R & D Pty Ltd
HSC PLA Pty Ltd
Northmoor Pla R & D Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Pla R & D Pty Ltd, Apelda Pla R & D Pty Ltd, Edzell Pla R & D Pty Ltd, Flair Pla R & D Pty Ltd, Heracles Pla R & D Pty Ltd, HSC PLA Pty Ltd, Northmoor Pla R & D Pty Ltd filed Critical Active Pla R & D Pty Ltd
Priority to AUPP0767A priority Critical patent/AUPP076797A0/en
Publication of AUPP076797A0 publication Critical patent/AUPP076797A0/en
Priority to AU15516/99A priority patent/AU1551699A/en
Priority to GB0013525A priority patent/GB2346885B/en
Priority to PCT/AU1998/000992 priority patent/WO1999029726A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AUPP0767A 1997-12-05 1997-12-05 Phospholipase inhibitor Abandoned AUPP076797A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AUPP0767A AUPP076797A0 (en) 1997-12-05 1997-12-05 Phospholipase inhibitor
AU15516/99A AU1551699A (en) 1997-12-05 1998-11-30 Phospholipase inhibitor
GB0013525A GB2346885B (en) 1997-12-05 1998-11-30 Phospholipase inhibitor
PCT/AU1998/000992 WO1999029726A1 (en) 1997-12-05 1998-11-30 Phospholipase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP0767A AUPP076797A0 (en) 1997-12-05 1997-12-05 Phospholipase inhibitor

Publications (1)

Publication Number Publication Date
AUPP076797A0 true AUPP076797A0 (en) 1998-01-08

Family

ID=3805050

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP0767A Abandoned AUPP076797A0 (en) 1997-12-05 1997-12-05 Phospholipase inhibitor

Country Status (3)

Country Link
AU (1) AUPP076797A0 (en)
GB (1) GB2346885B (en)
WO (1) WO1999029726A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP345098A0 (en) * 1998-05-11 1998-06-04 National Institute Of Biological Standards And Control, United Kingdom Novel anti-fibrinolytic agents
WO2000028997A1 (en) * 1998-11-12 2000-05-25 Analytica Ltd Phospholipase inhibitors for the treatment of cancer
IT1319158B1 (en) * 2000-12-15 2003-09-26 Angelo Michele Palmieri PHARMACEUTICAL COMPOSITION WITH ANTI-TUMOR ACTIVITY CONSTITUTING SNAKE BLOOD COMPONENTS AND METHOD FOR THEM
RU2291708C2 (en) * 2005-03-09 2007-01-20 Владимир Георгиевич Вискунов Agent for treatment and prophylaxis of acute pancreatitis and methods for its using
EP2923710A1 (en) 2014-03-27 2015-09-30 Universitätsklinikum Heidelberg Bacterial phospholipase inhibitors as modulator of colonic bacterial flora
MA40998A (en) * 2014-11-21 2017-09-26 Ophirex Inc THERAPIES AGAINST ENVENIMATION, AS WELL AS ASSOCIATED COMPOSITIONS, SYSTEMS AND PHARMACEUTICAL KITS
CN116585306B (en) * 2016-04-29 2025-06-20 奥菲瑞克斯股份有限公司 PLA2 inhibitors for the immediate treatment of hymenoptera poisoning and other conditions caused by histamine release
WO2018151867A1 (en) * 2017-02-17 2018-08-23 CAMRIS International, Inc. Universal antivenom
CN108703975A (en) * 2018-08-30 2018-10-26 黄汝怡 A kind of liniment treated poisonous insect and bitten
WO2021112615A1 (en) * 2019-12-05 2021-06-10 아주대학교산학협력단 Composition containing peptide or peptide compound as active ingredient, and medical use therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0931091A4 (en) * 1996-09-27 2000-06-14 Garvan Inst Med Res PLA 2 INHIBITORS

Also Published As

Publication number Publication date
GB0013525D0 (en) 2000-07-26
WO1999029726A1 (en) 1999-06-17
GB2346885A (en) 2000-08-23
GB2346885B (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU6477498A (en) Scale inhibitors
AU5523098A (en) Arylsulfonamides as phospholipase a2 inhibitors
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
PL342516A1 (en) Phospholipase a2 inhibitors
AU1709299A (en) Mixer-injectors
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU3102397A (en) Metalloprotease inhibitors
AU6882598A (en) Protein kinase inhibitor
AU7139598A (en) Protease inhibitors
AU5272198A (en) EMP-charge-eliminator
AU3120297A (en) Human phospholipase inhibitor
AU9746698A (en) 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
AUPP076797A0 (en) Phospholipase inhibitor
AU8673598A (en) Neuraminidase inhibitors
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU8997498A (en) Tryptase inhibitor
AU6185898A (en) Clavaspirins
AU6422798A (en) Stabilized urease inhibitor
AU9300298A (en) Protease inhibitors
AU6049796A (en) Lysyloxidase inhibitors
AU7761998A (en) Korrosionsschutzanstrichstoff
AU2812195A (en) Inhibitor
AU7252398A (en) Protease inhibitors